Yasmeen Rahimi's
Stock Forecasts

Yasmeen Rahimi win rate

16.67%

6/36 win trades

Yasmeen Rahimi is a Wall Street stock analyst with a 16.67% win rate, who was right in predicting 6 out of 36 price targets. Most frequently covered stocks by this analyst are EWTX, VRNS, UPB and SAGE. He has published 0 price targets in the last month and 6 last year.

Price targets by Yasmeen Rahimi

Company name & ticker Publish date Price target Price when posted Source Historical targets
UPB logo
Upstream Bio, Inc.
UPB
10 months ago $75 352.62% upside $28.02 StreetInsider Previous targets (0)
SAGE logo
Sage Therapeutics, Inc.
SAGE
10 months ago $26 199.19% upside $7.9 StreetInsider Previous targets (0)
ANAB logo
AnaptysBio, Inc.
ANAB
11 months ago $80 304.24% upside $34.74 StreetInsider Previous targets (0)
EWTX logo
Edgewise Therapeutics, Inc.
EWTX
11 months ago $51 287.68% upside $30.46 StreetInsider
BNTC logo
Benitec Biopharma Inc.
BNTC
11 months ago $30 138.85% upside $8.88 StreetInsider Previous targets (0)
NAMS logo
NewAmsterdam Pharma Company N.V.
NAMS
11 months ago $37 51.32% upside $15.95 StreetInsider Previous targets (0)
VRNS logo
Varonis Systems, Inc.
VRNS
about 1 year ago $48 -17.94% downside $55.59 StreetInsider
CYTK logo
Cytokinetics, Incorporated
CYTK
about 1 year ago $107 176.55% upside $53.21 StreetInsider Previous targets (0)
ARCT logo
Arcturus Therapeutics Holdings Inc.
ARCT
over 1 year ago $140 702.75% upside $39.42 StreetInsider Previous targets (0)
IMVT logo
Immunovant, Inc.
IMVT
over 1 year ago $57 284.61% upside $27.83 StreetInsider Previous targets (0)
MDGL logo
Madrigal Pharmaceuticals, Inc.
MDGL
over 1 year ago $336 -12.72% downside $221.76 StreetInsider Previous targets (0)
SLNO logo
Soleno Therapeutics, Inc.
SLNO
over 1 year ago $93 39.20% upside $42.42 StreetInsider Previous targets (0)
PLRX logo
Pliant Therapeutics, Inc.
PLRX
over 1 year ago $40 2566.66% upside $13.85 StreetInsider Previous targets (0)
CRNX logo
Crinetics Pharmaceuticals, Inc.
CRNX
over 1 year ago $97 220.76% upside $47.47 StreetInsider Previous targets (0)
DSGN logo
Design Therapeutics, Inc.
DSGN
over 1 year ago $12 132.10% upside $3.65 StreetInsider Previous targets (0)
VRNA logo
Verona Pharma plc
VRNA
over 1 year ago $36 -65.81% downside $15.8 StreetInsider Previous targets (0)

Other analysts covering same stocks

Covering:
Navin Jacob
UBS
75%
win rate
Covering:
Andrew Baum
Citigroup
66.67%
win rate
Steve Scala
Cowen & Co.
66.67%
win rate
Covering:
Colin Bristow
UBS
61.54%
win rate
Covering:
Laura Chico
Wedbush
57.14%
win rate